
FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer
The United States Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation for NEO100 (perillyl alcohol) in the treatment of pediatric-type diffuse high-grade gliomas, a life-threatening brain cancer, according to a news release …